CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 111 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q1 2021. The put-call ratio across all filers is 0.92 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $366,000 | -7.1% | 200,000 | 0.0% | 0.01% | 0.0% |
Q1 2021 | $394,000 | +282.5% | 200,000 | +1251.4% | 0.01% | +600.0% |
Q1 2019 | $103,000 | +19.8% | 14,800 | 0.0% | 0.00% | 0.0% |
Q4 2018 | $86,000 | -91.9% | 14,800 | -89.5% | 0.00% | -90.0% |
Q3 2018 | $1,062,000 | – | 140,715 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Knoll Capital Management, LLC | 5,045,870 | $1,273,000 | 0.73% |
ETF MANAGERS GROUP, LLC | 7,062,485 | $1,787,000 | 0.05% |
Ikarian Capital, LLC | 862,527 | $217,000 | 0.04% |
IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 457,209 | $115,000 | 0.02% |
Platform Technology Partners | 33,750 | $9,000 | 0.01% |
PINNACLE ASSOCIATES LTD | 910,006 | $230,000 | 0.01% |
CJM Wealth Advisers, Ltd. | 30,465 | $7,683 | 0.01% |
Mirae Asset Global Investments Co., Ltd. | 4,029,171 | $1,016,000 | 0.00% |
Vident Investment Advisory, LLC | 267,612 | $67,000 | 0.00% |
Aries Wealth Management | 15,400 | $4,000 | 0.00% |